SPONSOR
Replimune Inc.
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2
Conditions studied: MelanomaMetastatic MelanomaAdvanced Solid TumorHepatocellular CarcinomaMerkel Cell CarcinomaBasal Cell CarcinomaLocally Advanced Cutaneous Squamous Cell CarcinomaCancer
NCT06887348
Recruiting
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
Melanoma
NCT04349436 Phase 1, Phase 2
Recruiting
Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies
Merkel Cell Carcinoma